CHEN; Kevin X

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHEN; Kevin X.The latest application filed is for "salt and crystal form of mtorc1/2 dual kinase activity inhibitor and preparation method therefor".

Company Profile

13.52.69

CHEN; Kevin X - Shanghai CN
CHEN; Kevin X. - Shanghai CN
Chen; Kevin X - Jiangsu CN
CHEN; KEVIN X - Shanhai CN
CHEN; Kevin X - Lianyungang City Jiangsu
CHEN; Kevin X - Nanjing Jiangsu
Chen; Kevin X. - Cambridge MA
Chen; Kevin X. - Edison NJ US
Chen; Kevin X. - Waigaoqiao FTZ CN
Chen; Kevin X. - Iselin NJ
Chen; Kevin X - Edison NJ
Chen; Kevin X. - Piscataway NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Salt And Crystal Form Of Mtorc1/2 Dual Kinase Activity Inhibitor And Preparation Method Therefor App 20220306622 - CHEN; Kevin X ; et al.	2022-09-29
Macrocyclic Derivatives As Factor Xia Inhibitors App 20220281868 - CAI; Yaxian ; et al.	2022-09-08
Quinazoline And Cinnoline Derivatives As Dna-pk Inhibitor App 20220267310 - Chen; Kevin X ; et al.	2022-08-25
Crystal Form And Salt Of Quinazoline Compound And Preparation Method Thereof App 20220242851 - CHEN; Kevin X. ; et al.	2022-08-04
Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors Grant 11,377,444 - Chen , et al. July 5, 2	2022-07-05
Salt Form And Crystal Form Of A2a Receptor Antagonist And Preparation Method Therefor App 20220185825 - CHEN; Kevin X ; et al.	2022-06-16
Anti-influenza Virus Pyrimidine Derivative App 20220135558 - Xiong; Jian ; et al.	2022-05-05
Therapeutic Compounds And Uses Thereof App 20220127265 - Cyr; Patrick ; et al.	2022-04-28
Fused ring derivative as A.sub.2A receptor inhibitor Grant 11,312,715 - Chen , et al. April 26, 2	2022-04-26
Therapeutic compounds and uses thereof Grant 11,247,989 - Cyr , et al. February 15, 2	2022-02-15
Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method thereof Grant 11,174,270 - Xiong , et al. November 16, 2	2021-11-16
Pyrrolo[2,1-f][1,2,4]triazine Derivatives Serving As Selective Her2 Inhibitors And Application Thereof App 20210323979 - CHEN; Kevin X ; et al.	2021-10-21
Anti-influenza virus pyrimidine derivative Grant 11,136,319 - Xiong , et al. October 5, 2	2021-10-05
Biheteroaryl compounds and uses thereof Grant 11,129,832 - Estrada , et al. September 28, 2	2021-09-28
[1,2,4]triazolo[1,5-c]pyrimidine derivative as A.sub.2A receptor inhibitor Grant 11,117,899 - Chen , et al. September 14, 2	2021-09-14
Imidaxopyrolone Compound And Application Thereof App 20210230164 - CHEN; Kevin X ; et al.	2021-07-29
[1,2,4]triazolo[1,5-c]pyrimidine derivative as A.sub.2A receptor inhibitor Grant 11,066,411 - Chen , et al. July 20, 2	2021-07-20
Borate Of Azetidine Derivative App 20210163507 - Xiong; Jian ; et al.	2021-06-03
Azetidine derivative Grant 11,014,943 - Xiong , et al. May 25, 2	2021-05-25
Crystal Form And Salt Type Of Triazolopyrimidine Compound And Preparation Method Thereof App 20210094957 - Chen; Kevin X. ; et al.	2021-04-01
Quinazoline Derivative And Use Thereof App 20210078958 - CHEN; Kevin X. ; et al.	2021-03-18
Anti-influenza Virus Pyrimidine Derivative App 20210032238 - Xiong; Jian ; et al.	2021-02-04
Crystal Form of 3,4-Dihydrothieno[3,2-D]Pyrimidine Compound and Preparation Method Thereof App 20210024538 - Xiong; Jian ; et al.	2021-01-28
Crystal Form And Salt Form Of Pyridoimidazole Compound And Preparation Method Therefor App 20200407354 - Xiong; Jian ; et al.	2020-12-31
Anti-HCMV virus compound Grant 10,851,112 - Xiong , et al. December 1, 2	2020-12-01
Pyridopyrimidine Compounds Acting As Mtorc 1/2 Double-kinase Inhibitors App 20200339568 - CHEN; Kevin X ; et al.	2020-10-29
Fused Ring Derivative As A2a Receptor Inhibitor App 20200239465 - CHEN; Kevin X ; et al.	2020-07-30
Bicylic Compound Acting As An Inhibitor App 20200231597 - CHEN; Kevin X ; et al.	2020-07-23
Biheteroaryl Compounds And Uses Thereof App 20200188397 - Estrada; Anthony ; et al.	2020-06-18
[1,2,4]triazolo[1,5-c]pyrimidine Derivative As A2a Receptor Inhibitor App 20200131184 - CHEN; KEVIN X ; et al.	2020-04-30
Azetidine Derivative App 20200115392 - XIONG; Jian ; et al.	2020-04-16
Therapeutic Compounds And Uses Thereof App 20190241558 - Cyr; Patrick ; et al.	2019-08-08
Anti-hcmv Virus Compound App 20190202838 - XIONG; Jian ; et al.	2019-07-04
Biheteroaryl compounds and uses thereof Grant 10,010,549 - Estrada , et al. July 3, 2	2018-07-03
Biheteroaryl Compounds And Uses Thereof App 20180133219 - Estrada; Anthony ; et al.	2018-05-17
Therapeutic Compounds And Uses Thereof App 20170333406 - Adler; Marc ; et al.	2017-11-23
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases Grant 9,796,705 - Chen , et al. October 24, 2	2017-10-24
Therapeutic compounds and uses thereof Grant 9,763,922 - Adler , et al. September 19, 2	2017-09-19
Fused Tricyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20170008879 - Chen; Kevin X. ; et al.	2017-01-12
5'-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases Grant 9,408,863 - Verma , et al. August 9, 2	2016-08-09
Therapeutic Compounds And Uses Thereof App 20160158207 - Adler; Marc ; et al.	2016-06-09
Biheteroaryl Compounds And Uses Thereof App 20160052940 - ESTRADA; ANTHONY ; et al.	2016-02-25
Fused tricyclic aryl compounds useful for the treatment of viral diseases Grant 9,139,569 - Rosenblum , et al. September 22, 2	2015-09-22
Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C Grant 8,980,920 - Zeng , et al. March 17, 2	2015-03-17
Tricyclic indole derivatives and methods of use thereof Grant 8,901,139 - Venkatraman , et al. December 2, 2	2014-12-02
5'-substituted Nucleoside Analogs And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140221304 - Verma; Vishal A. ; et al.	2014-08-07
2'-azido Substituted Nucleoside Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases App 20140206640 - Girijavallabhan; Vinay ; et al.	2014-07-24
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C Grant 8,772,505 - Chen , et al. July 8, 2	2014-07-08
Substituted indole derivatives and methods of use thereof Grant 8,614,229 - Anilkumar , et al. December 24, 2	2013-12-24
4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections Grant 8,557,848 - Chen , et al. October 15, 2	2013-10-15
Antiviral Compounds Composed of Three Aligned Aryl Moieties to Treat Diseases such as Hepatitis C App 20130164258 - Chen; Kevin X. ; et al.	2013-06-27
Fused Tricyclic Compounds And Methods Of Use Thereof For The Treatment Of Viral Diseas App 20130156731 - Chen; Kevin X. ; et al.	2013-06-20
3-aminosulfonyl substituted indole derivatives and methods of use thereof Grant 8,377,928 - Chen , et al. February 19, 2	2013-02-19
Fused Tricyclic Compounds And Derivatives Thereof Useful For The Treatment Of Viral Diseases App 20120276047 - Rosenblum; Stuart B. ; et al.	2012-11-01
Antiviral Compounds Of Three Linked Aryl Moieties To Treat Diseases Such As Hepatitis C App 20120258078 - Zeng; Qingbei ; et al.	2012-10-11
Fused Tricyclic Aryl Compounds Useful For The Treatment Of Viral Diseases App 20120251491 - Rosenblum; Stuart B. ; et al.	2012-10-04
5, 6-ring annulated indole derivatives and use thereof Grant 8,268,803 - Bennett , et al. September 18, 2	2012-09-18
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant RE43,298 - Saksena , et al. April 3, 2	2012-04-03
2,3-substituted indole derivatives for treating viral infections Grant 8,143,305 - Anilkumar , et al. March 27, 2	2012-03-27
Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 8,067,379 - Bennett , et al. November 29, 2	2011-11-29
Tricyclic Indole Derivatives And Methods Of Use Thereof App 20110189127 - Venkatraman; Srikanth ; et al.	2011-08-04
Novel Peptides As Ns3-serine Protease Inhibitors Of Hepatitis C Virus App 20110117057 - Saksena; Anil K. ; et al.	2011-05-19
Substituted Indole Derivatives And Methods Of Use Thereof App 20110104110 - Anikumar; Gopinadhan N. ; et al.	2011-05-05
Tetracyclic Indole Derivatives And Their Use For Treating Or Preventing Viral Infections App 20110104109 - Bennett; Frank ; et al.	2011-05-05
2,3-substituted Indole Derivatives For Treating Viral Infections App 20110033417 - Anilkumar; Gopinadhan N. ; et al.	2011-02-10
5, 6-ring Annulated Indole Derivatives And Use Thereof App 20100322901 - Bennett; Frank ; et al.	2010-12-23
3-aminosulfonyl Substituted Indole Derivatives And Methods Of Use Thereof App 20100260711 - Chen; Kevin X. ; et al.	2010-10-14
Compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 7,759,499 - Venkatraman , et al. July 20, 2	2010-07-20
Compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 7,718,691 - Venkatraman , et al. May 18, 2	2010-05-18
4,5-ring Annulated Indole Derivatives For Treating Or Preventing Of Hcv And Related Viral Infections App 20100098661 - Chen; Kevin X. ; et al.	2010-04-22
Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus Grant 7,619,094 - Chen , et al. November 17, 2	2009-11-17
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,595,299 - Saksena , et al. September 29, 2	2009-09-29
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,592,316 - Njoroge , et al. September 22, 2	2009-09-22
Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus Grant 7,449,447 - Chen , et al. November 11, 2	2008-11-11
Compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 7,425,576 - Arasappan , et al. September 16, 2	2008-09-16
Inhibitors of hepatitis C virus NS3 protease Grant 7,423,058 - Bogen , et al. September 9, 2	2008-09-09
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20070232549 - Njoroge; F. George ; et al.	2007-10-04
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,244,721 - Saksena , et al. July 17, 2	2007-07-17
Novel compounds as inhibitors of hepatitis C virus NS3 serine protease App 20070142300 - Arasappan; Ashok ; et al.	2007-06-21
Novel inhibitors of Hepatitis C virus NS3 protease App 20070142301 - Bogen; Stephane L. ; et al.	2007-06-21
Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus App 20070093430 - Chen; Kevin X. ; et al.	2007-04-26
Inhibitors of hepatitis C virus NS3 protease Grant 7,205,330 - Bogen , et al. April 17, 2	2007-04-17
Compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 7,192,957 - Venkatraman , et al. March 20, 2	2007-03-20
Compounds as inhibitors of hepatitis C virus NS3 serine protease Grant 7,186,747 - Arasappan , et al. March 6, 2	2007-03-06
Novel compounds as inhibitors of hepatitis C virus NS3 serine protease App 20070049536 - Venkatraman; Srikanth ; et al.	2007-03-01
Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease App 20070042968 - Bennett; Frank ; et al.	2007-02-22
Novel compounds as inhibitors of hepatitis C virus NS3 serine protease App 20070032434 - Venkatraman; Srikanth ; et al.	2007-02-08
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20070032433 - Saksena; Anil K. ; et al.	2007-02-08
Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus Grant 7,173,057 - Chen , et al. February 6, 2	2007-02-06
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,169,760 - Saksena , et al. January 30, 2	2007-01-30
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20060205672 - Saksena; Anil K. ; et al.	2006-09-14
Peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 7,012,066 - Saksena , et al. March 14, 2	2006-03-14
Novel compounds as inhibitors of hepatitis C virus NS3 serine protease App 20050288233 - Venkatraman, Srikanth ; et al.	2005-12-29
Novel inhibitors of hepatitis C virus NS3 protease App 20050267043 - Bogen, Stephane L. ; et al.	2005-12-01
Novel compounds as inhibitors of hepatitis C virus NS3 serine protease App 20050245458 - Arasappan, Ashok ; et al.	2005-11-03
Novel ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus App 20050222047 - Chen, Kevin X. ; et al.	2005-10-06
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20050176648 - Saksena, Anil K. ; et al.	2005-08-11
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties Grant 6,914,122 - Venkatraman , et al. July 5, 2	2005-07-05
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus Grant 6,911,428 - Zhu , et al. June 28, 2	2005-06-28
Compounds as NS3-serine protease inhibitors of hepatitis C virus Grant 6,894,072 - Arasappan , et al. May 17, 2	2005-05-17
Novel peptidomimetic NS3-serine protease inhibitors of hepatitis C virus App 20050085425 - Chen, Kevin X. ; et al.	2005-04-21
Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties Grant 6,846,802 - Chen , et al. January 25, 2	2005-01-25
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20040254117 - Saksena, Anil K. ; et al.	2004-12-16
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20030216325 - Saksena, Anil K. ; et al.	2003-11-20
Novel compounds as NS3-serine protease inhibitors of hepatitis C virus App 20030207861 - Arasappan, Ashok ; et al.	2003-11-06
Novel peptides as NS3-serine protease inhibitors of hepatitis C virus App 20020160962 - Saksena, Anil K. ; et al.	2002-10-31
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus App 20020147139 - Zhu, Zhaoning ; et al.	2002-10-10
Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties App 20020107181 - Chen, Kevin X. ; et al.	2002-08-08
Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties App 20020016294 - Venkatraman, Srikanth ; et al.	2002-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.